Safinamide

Synchemia is a leading supplier of pharmaceutical-grade Safinamide impurities, offering high-quality reference impurity standards for research and analytical purposes. Safinamide Safinamide is a medication used primarily in the treatment of Parkinson’s disease, particularly in patients experiencing “off” episodes while taking levodopa or other dopaminergic therapies. Indication: Adjunct treatment for Parkinson’s disease patients experiencing motor fluctuations (i.e., "off" episodes) despite being on a stable dose of levodopa. When added to levodopa: Increases "on" time without troublesome dyskinesia. Decreases "off" time (periods when medication wears off and symptoms return).

Safinamide | CAS NO: 133865-89-1, also known as Safinamide is chemically expressed as (S)-2-((4-((3-fluorobenzyl)oxy)benzyl)amino)propanamide. Safinamide is supplied with comprehensive characterization data, in full compliance with applicable regulatory guidelines. Synchemia is a leading supplier and exporter of Safinamide. All Synchemia products are strictly intended for analytical testing purposes only and not for human use.